
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7
Bo Meng, Steven A. Kemp, Guido Papa, et al.
Cell Reports (2021) Vol. 35, Iss. 13, pp. 109292-109292
Open Access | Times Cited: 412
Bo Meng, Steven A. Kemp, Guido Papa, et al.
Cell Reports (2021) Vol. 35, Iss. 13, pp. 109292-109292
Open Access | Times Cited: 412
Showing 1-25 of 412 citing articles:
SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion
Petra Mlčochová, Steven A. Kemp, Mahesh Shanker Dhar, et al.
Nature (2021) Vol. 599, Iss. 7883, pp. 114-119
Open Access | Times Cited: 1274
Petra Mlčochová, Steven A. Kemp, Mahesh Shanker Dhar, et al.
Nature (2021) Vol. 599, Iss. 7883, pp. 114-119
Open Access | Times Cited: 1274
The biological and clinical significance of emerging SARS-CoV-2 variants
Kaiming Tao, Philip L. Tzou, Janin Nouhin, et al.
Nature Reviews Genetics (2021) Vol. 22, Iss. 12, pp. 757-773
Open Access | Times Cited: 976
Kaiming Tao, Philip L. Tzou, Janin Nouhin, et al.
Nature Reviews Genetics (2021) Vol. 22, Iss. 12, pp. 757-773
Open Access | Times Cited: 976
Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity
Bo Meng, Adam Abdullahi, Isabella A. T. M. Ferreira, et al.
Nature (2022) Vol. 603, Iss. 7902, pp. 706-714
Open Access | Times Cited: 956
Bo Meng, Adam Abdullahi, Isabella A. T. M. Ferreira, et al.
Nature (2022) Vol. 603, Iss. 7902, pp. 706-714
Open Access | Times Cited: 956
The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic
Markus Hoffmann, Nadine Krüger, Sebastian Schulz, et al.
Cell (2021) Vol. 185, Iss. 3, pp. 447-456.e11
Open Access | Times Cited: 869
Markus Hoffmann, Nadine Krüger, Sebastian Schulz, et al.
Cell (2021) Vol. 185, Iss. 3, pp. 447-456.e11
Open Access | Times Cited: 869
The evolution of SARS-CoV-2
Peter V. Markov, Mahan Ghafari, Martin Beer, et al.
Nature Reviews Microbiology (2023) Vol. 21, Iss. 6, pp. 361-379
Open Access | Times Cited: 703
Peter V. Markov, Mahan Ghafari, Martin Beer, et al.
Nature Reviews Microbiology (2023) Vol. 21, Iss. 6, pp. 361-379
Open Access | Times Cited: 703
SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway
Brian J. Willett, Joe Grove, Oscar A. MacLean, et al.
Nature Microbiology (2022) Vol. 7, Iss. 8, pp. 1161-1179
Open Access | Times Cited: 531
Brian J. Willett, Joe Grove, Oscar A. MacLean, et al.
Nature Microbiology (2022) Vol. 7, Iss. 8, pp. 1161-1179
Open Access | Times Cited: 531
The N501Y spike substitution enhances SARS-CoV-2 infection and transmission
Yang Liu, Jianying Liu, Kenneth S. Plante, et al.
Nature (2021) Vol. 602, Iss. 7896, pp. 294-299
Open Access | Times Cited: 483
Yang Liu, Jianying Liu, Kenneth S. Plante, et al.
Nature (2021) Vol. 602, Iss. 7896, pp. 294-299
Open Access | Times Cited: 483
The emergence and epidemic characteristics of the highly mutated SARS‐CoV‐2 Omicron variant
Dandan Tian, Yanhong Sun, Huihong Xu, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 6, pp. 2376-2383
Open Access | Times Cited: 428
Dandan Tian, Yanhong Sun, Huihong Xu, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 6, pp. 2376-2383
Open Access | Times Cited: 428
SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution
Jiří Zahradník, Shir Marciano, Maya Shemesh, et al.
Nature Microbiology (2021) Vol. 6, Iss. 9, pp. 1188-1198
Open Access | Times Cited: 377
Jiří Zahradník, Shir Marciano, Maya Shemesh, et al.
Nature Microbiology (2021) Vol. 6, Iss. 9, pp. 1188-1198
Open Access | Times Cited: 377
SARS-CoV-2 Variants, Vaccines, and Host Immunity
Priyal Mistry, Fatima Barmania, Juanita Mellet, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 275
Priyal Mistry, Fatima Barmania, Juanita Mellet, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 275
SARS-CoV-2 Variants of Concern
Jun Yong Choi, Davey M. Smith
Yonsei Medical Journal (2021) Vol. 62, Iss. 11, pp. 961-961
Open Access | Times Cited: 274
Jun Yong Choi, Davey M. Smith
Yonsei Medical Journal (2021) Vol. 62, Iss. 11, pp. 961-961
Open Access | Times Cited: 274
Virological characteristics of the SARS-CoV-2 Omicron BA.2 subvariants, including BA.4 and BA.5
Izumi Kimura, Daichi Yamasoba, Tomokazu Tamura, et al.
Cell (2022) Vol. 185, Iss. 21, pp. 3992-4007.e16
Open Access | Times Cited: 238
Izumi Kimura, Daichi Yamasoba, Tomokazu Tamura, et al.
Cell (2022) Vol. 185, Iss. 21, pp. 3992-4007.e16
Open Access | Times Cited: 238
Omicron: What Makes the Latest SARS-CoV-2 Variant of Concern So Concerning?
Christoph Jung, Dorota Kmieć, Lennart Koepke, et al.
Journal of Virology (2022) Vol. 96, Iss. 6
Open Access | Times Cited: 202
Christoph Jung, Dorota Kmieć, Lennart Koepke, et al.
Journal of Virology (2022) Vol. 96, Iss. 6
Open Access | Times Cited: 202
Omicron (BA.1) and sub‐variants (BA.1.1, BA.2, and BA.3) of SARS‐CoV‐2 spike infectivity and pathogenicity: A comparative sequence and structural‐based computational assessment
Suresh Kumar, Kalimuthu Karuppanan, Gunasekaran Subramaniam
Journal of Medical Virology (2022) Vol. 94, Iss. 10, pp. 4780-4791
Open Access | Times Cited: 189
Suresh Kumar, Kalimuthu Karuppanan, Gunasekaran Subramaniam
Journal of Medical Virology (2022) Vol. 94, Iss. 10, pp. 4780-4791
Open Access | Times Cited: 189
Mutations and Evolution of the SARS-CoV-2 Spike Protein
Nicholas Magazine, Tianyi Zhang, Yingying Wu, et al.
Viruses (2022) Vol. 14, Iss. 3, pp. 640-640
Open Access | Times Cited: 188
Nicholas Magazine, Tianyi Zhang, Yingying Wu, et al.
Viruses (2022) Vol. 14, Iss. 3, pp. 640-640
Open Access | Times Cited: 188
A year of genomic surveillance reveals how the SARS-CoV-2 pandemic unfolded in Africa
Eduan Wilkinson, Marta Giovanetti, Houriiyah Tegally, et al.
Science (2021) Vol. 374, Iss. 6566, pp. 423-431
Open Access | Times Cited: 181
Eduan Wilkinson, Marta Giovanetti, Houriiyah Tegally, et al.
Science (2021) Vol. 374, Iss. 6566, pp. 423-431
Open Access | Times Cited: 181
The SARS-CoV-2 Lambda variant exhibits enhanced infectivity and immune resistance
Izumi Kimura, Yusuke Kosugi, Jiaqi Wu, et al.
Cell Reports (2021) Vol. 38, Iss. 2, pp. 110218-110218
Open Access | Times Cited: 180
Izumi Kimura, Yusuke Kosugi, Jiaqi Wu, et al.
Cell Reports (2021) Vol. 38, Iss. 2, pp. 110218-110218
Open Access | Times Cited: 180
The Impact of Evolving SARS-CoV-2 Mutations and Variants on COVID-19 Vaccines
Gary R. McLean, Jeremy P. Kamil, Benhur Lee, et al.
mBio (2022) Vol. 13, Iss. 2
Open Access | Times Cited: 174
Gary R. McLean, Jeremy P. Kamil, Benhur Lee, et al.
mBio (2022) Vol. 13, Iss. 2
Open Access | Times Cited: 174
SARS‐CoV‐2 Alpha, Beta, and Delta variants display enhanced Spike‐mediated syncytia formation
Maaran Michael Rajah, Mathieu Hubert, Elodie Bishop, et al.
The EMBO Journal (2021) Vol. 40, Iss. 24
Open Access | Times Cited: 170
Maaran Michael Rajah, Mathieu Hubert, Elodie Bishop, et al.
The EMBO Journal (2021) Vol. 40, Iss. 24
Open Access | Times Cited: 170
COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection
Wei-Yu Chi, Yen-Der Li, Hsin‐Che Huang, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 164
Wei-Yu Chi, Yen-Der Li, Hsin‐Che Huang, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 164
The Mechanism and Consequences of SARS-CoV-2 Spike-Mediated Fusion and Syncytia Formation
Maaran Michael Rajah, Annie Bernier, Julian Buchrieser, et al.
Journal of Molecular Biology (2021) Vol. 434, Iss. 6, pp. 167280-167280
Open Access | Times Cited: 153
Maaran Michael Rajah, Annie Bernier, Julian Buchrieser, et al.
Journal of Molecular Biology (2021) Vol. 434, Iss. 6, pp. 167280-167280
Open Access | Times Cited: 153
The relationship between COVID‐19 viral load and disease severity: A systematic review
Omid Dadras, Amir Masoud Afsahi, Zahra Pashaei, et al.
Immunity Inflammation and Disease (2021) Vol. 10, Iss. 3
Open Access | Times Cited: 142
Omid Dadras, Amir Masoud Afsahi, Zahra Pashaei, et al.
Immunity Inflammation and Disease (2021) Vol. 10, Iss. 3
Open Access | Times Cited: 142
The hyper-transmissible SARS-CoV-2 Omicron variant exhibits significant antigenic change, vaccine escape and a switch in cell entry mechanism
Brian J. Willett, Joe Grove, Oscar A. MacLean, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 135
Brian J. Willett, Joe Grove, Oscar A. MacLean, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 135
The origins and molecular evolution of SARS-CoV-2 lineage B.1.1.7 in the UK
Verity Hill, Louis du Plessis, Thomas P. Peacock, et al.
Virus Evolution (2022) Vol. 8, Iss. 2
Open Access | Times Cited: 127
Verity Hill, Louis du Plessis, Thomas P. Peacock, et al.
Virus Evolution (2022) Vol. 8, Iss. 2
Open Access | Times Cited: 127
Structural and antigenic variations in the spike protein of emerging SARS-CoV-2 variants
Anshumali Mittal, Arun Khattri, Vikash Verma
PLoS Pathogens (2022) Vol. 18, Iss. 2, pp. e1010260-e1010260
Open Access | Times Cited: 115
Anshumali Mittal, Arun Khattri, Vikash Verma
PLoS Pathogens (2022) Vol. 18, Iss. 2, pp. e1010260-e1010260
Open Access | Times Cited: 115